@Article{Krawczyk2015,
journal="Contemporary Oncology/Współczesna Onkologia",
issn="1428-2526",
volume="19",
number="3",
year="2015",
title="Letter to the editor concerning first-line therapy with afatinib – an irreversible EGFR TKI and overall survival of NSCLC patients with EGFR gene mutations",
author="Krawczyk, Paweł
and Powrózek, Tomasz
and Nicoś, Marcin
and Milanowski, Janusz",
pages="250--251",
doi="10.5114/wo.2015.52660",
url="http://dx.doi.org/10.5114/wo.2015.52660"
}